What has the mdx mouse model of duchenne muscular dystrophy contributed to our understanding of this disease?
Authors:
- 11 February 2015
- journal article
- review article
- Published by Springer Nature in Journal of Muscle Research and Cell Motility
- Vol. 36 (2) , 155-167
Abstract
Duchenne muscular dystrophy (DMD) is a fatal X-chromosome linked recessive disorder caused by the truncation or deletion of the dystrophin gene. The most widely used animal model of this disease is the dystrophin-deficient mdx mouse which was first discovered 30 years ago. Despite its extensive use in DMD research, no effective treatment has yet been developed for this devastating disease. This review explores what we have learned from this mouse model regarding the pathophysiology of DMD and asks if it has a future in providing a better more thorough understanding of this disease or if it will bring us any closer to improving the outlook for DMD patients.Keywords
This publication has 160 references indexed in Scilit:
- Quantitative evaluation of the beneficial effects in the mdx mouse of epigallocatechin gallate, an antioxidant polyphenol from green teaHistochemistry and Cell Biology, 2012
- Exon skipping and dystrophin restoration in patients with Duchenne muscular dystrophy after systemic phosphorodiamidate morpholino oligomer treatment: an open-label, phase 2, dose-escalation studyThe Lancet, 2011
- CINRG pilot trial of coenzyme Q10 in steroid‐treated duchenne muscular dystrophyMuscle & Nerve, 2011
- The Status of Exon Skipping as a Therapeutic Approach to Duchenne Muscular DystrophyMolecular Therapy, 2011
- Debio-025 is more effective than prednisone in reducing muscular pathology in mdx miceNeuromuscular Disorders, 2010
- Effects of prednisolone on skeletal muscle contractility in mdx miceMuscle & Nerve, 2009
- Investigation of Debio 025, a cyclophilin inhibitor, in the dystrophicmdxmouse, a model for Duchenne muscular dystrophyBritish Journal of Pharmacology, 2008
- Towards developing standard operating procedures for pre-clinical testing in the mdx mouse model of Duchenne muscular dystrophyNeurobiology of Disease, 2008
- Dystrophin-deficient cardiomyopathy in mouse: Expression of Nox4 and Lox are associated with fibrosis and altered functional parameters in the heartNeuromuscular Disorders, 2008
- Dystrophin expression in the mdx mouse after localised and systemic administration of a morpholino antisense oligonucleotideThe Journal of Gene Medicine, 2005